Literature DB >> 24818904

In vitro assays to monitor the activity of Pseudomonas aeruginosa Type III secreted proteins.

Stephanie L Rolsma1, Dara W Frank.   

Abstract

Pseudomonas aeruginosa secretes numerous toxins and destructive enzymes that play distinct roles in pathogenesis. The Type III secretion system (T3SS) of Pseudomonas is a system that delivers a subset of toxins directly into the cytoplasm of eukaryotic cells. The secreted effectors include ExoS, ExoT, ExoU, and ExoY. In this chapter, we describe methods to induce T3S expression and measure the enzymatic activities of each effector in in vitro assays. ExoU is a phospholipase and its activity can be measured in a fluorescence-based assay monitoring the cleavage of the fluorogenic substrate, PED6. ExoS and ExoT both possess ADP-ribosyltransferase (ADPRT) and GTPase-activating protein (GAP) activity. ADPRT activity can be assessed by using radiolabeled nicotinamide adenine dinucleotide (NAD(+)) and measuring the covalent incorporation of ADP-ribose into a target protein. GAP activity is measured by the release of radiolabeled phosphate from [γ-(32)P]GTP-bound target proteins. In accordance with recent trends towards reducing the use of radioactivity in the laboratory, alternative assays using fluorescent or biotin-labeled reagents are described. ExoY is a nucleotidyl cyclase; cAMP production stimulated by ExoY can be monitored using reverse-phase HPLC or with commercially available immunological assays.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24818904      PMCID: PMC5860653          DOI: 10.1007/978-1-4939-0473-0_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  79 in total

1.  The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins.

Authors:  K J Pederson; A J Vallis; K Aktories; D W Frank; J T Barbieri
Journal:  Mol Microbiol       Date:  1999-04       Impact factor: 3.501

2.  Examination of the coordinate effects of Pseudomonas aeruginosa ExoS on Rac1.

Authors:  Claudia L Rocha; Elizabeth A Rucks; Deanne M Vincent; Joan C Olson
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  ADP-ribosylation of p21ras and related proteins by Pseudomonas aeruginosa exoenzyme S.

Authors:  J Coburn; D M Gill
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

4.  Exotoxins of Pseudomonas aeruginosa. I. Factors that influence the production of exotoxin A.

Authors:  P V Liu
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

5.  An electrostatic steering mechanism of Cdc42 recognition by Wiskott-Aldrich syndrome proteins.

Authors:  Lars Hemsath; Radovan Dvorsky; Dennis Fiegen; Marie-France Carlier; Mohammad Reza Ahmadian
Journal:  Mol Cell       Date:  2005-10-28       Impact factor: 17.970

6.  Pseudomonas aeruginosa exotoxin Y is a promiscuous cyclase that increases endothelial tau phosphorylation and permeability.

Authors:  Cristhiaan D Ochoa; Mikhail Alexeyev; Viktoriya Pastukh; Ron Balczon; Troy Stevens
Journal:  J Biol Chem       Date:  2012-05-25       Impact factor: 5.157

7.  Pseudomonas aeruginosa causes acute lung injury via the catalytic activity of the patatin-like phospholipase domain of ExoU.

Authors:  Ravi R Pankhaniya; Miki Tamura; Leonard R Allmond; Kiyoshi Moriyama; Temitayo Ajayi; Jeanine P Wiener-Kronish; Teiji Sawa
Journal:  Crit Care Med       Date:  2004-11       Impact factor: 7.598

8.  The ADP ribosyltransferase domain of Pseudomonas aeruginosa ExoT contributes to its biological activities.

Authors:  L Garrity-Ryan; S Shafikhani; P Balachandran; L Nguyen; J Oza; T Jakobsen; J Sargent; X Fang; S Cordwell; M A Matthay; J N Engel
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S.

Authors:  T I Nicas; B H Iglewski
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

10.  Exoenzyme S shows selective ADP-ribosylation and GTPase-activating protein (GAP) activities towards small GTPases in vivo.

Authors:  Maria L Henriksson; Charlotta Sundin; Anna L Jansson; Ake Forsberg; Ruth H Palmer; Bengt Hallberg
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

View more
  3 in total

1.  An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections.

Authors:  Martina Koeva; Alina D Gutu; Wesley Hebert; Jeffrey D Wager; Lael M Yonker; George A O'Toole; Frederick M Ausubel; Samuel M Moskowitz; Diane Joseph-McCarthy
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

Review 2.  The role of Type III secretion system in the pathogenesis of Pseudomonas aeruginosa microbial keratitis.

Authors:  Justin J Yang; Kai-Si Claire Tsuei; Elizabeth P Shen
Journal:  Tzu Chi Med J       Date:  2021-05-11

Review 3.  Exoproteomics for Better Understanding Pseudomonas aeruginosa Virulence.

Authors:  Salomé Sauvage; Julie Hardouin
Journal:  Toxins (Basel)       Date:  2020-09-04       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.